-
Publication Venue For
-
New Paradigms to Address Long-Term Exercise Adherence, An Achilles Heel of Lifestyle Interventions..
147:1565-1567.
2023
-
Effect of Torsemide vs Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
2023
-
Sarcopenia and Cardiovascular Diseases..
147:1534-1553.
2023
-
Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association..
147:1317-1343.
2023
-
Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
2023
-
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial..
147:1067-1078.
2023
-
Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial..
147:1004-1013.
2023
-
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors..
147:1026-1038.
2023
-
Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation..
147:925-929.
2023
-
Anesthetic Care of the Pregnant Patient With Cardiovascular Disease: A Scientific Statement From the American Heart Association..
147:e657-e673.
2023
-
Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks..
147:850-863.
2023
-
Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF"..
147:922-923.
2023
-
Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials..
147:812-823.
2023
-
Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization..
147:824-840.
2023
-
Cardiac Myosin Inhibitors: Unlocking Potential to Improve Treatment in Hypertrophic Cardiomyopathy..
147:700-702.
2023
-
Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study..
147:694-696.
2023
-
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER..
147:624-634.
2023
-
Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex..
147:586-596.
2023
-
Seventh Annual Go Red for Women Issue..
147:519-520.
2023
-
A New Era in Cardiac Rehabilitation Delivery: Research Gaps, Questions, Strategies, and Priorities..
147:254-266.
2023
-
Cardiac Troponin I-Interacting Kinase Affects Cardiomyocyte S-Phase Activity but Not Cardiomyocyte Proliferation..
147:142-153.
2023
-
Prospective Association of Daily Steps With Cardiovascular Disease: A Harmonized Meta-Analysis..
147:122-131.
2023
-
Survival After Invasive or Conservative Management of Stable Coronary Disease..
147:8-19.
2023
-
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines..
146:e334-e482.
2022
-
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial..
146:1735-1745.
2022
-
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial..
146:1749-1757.
2022
-
Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study..
146:1638-1640.
2022
-
Assessing the Impact of the American Heart Association's Research Portfolio: A Scientific Statement From the American Heart Association..
146:e246-e256.
2022
-
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials..
146:1329-1343.
2022
-
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction..
146:1196-1206.
2022
-
Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial..
146:958-960.
2022
-
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF..
146:808-818.
2022
-
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab..
146:657-672.
2022
-
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes..
146:676-686.
2022
-
Predictive Utility of a Validated Polygenic Risk Score for Long-Term Risk of Coronary Heart Disease in Young and Middle-Aged Adults..
146:587-596.
2022
-
Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial..
146:535-547.
2022
-
Eligibility for Noninvasive Testing Based on the 2021 American Heart Association/American College of Cardiology Guideline for the Evaluation and Diagnosis of Stable Chest Pain: Implications From the PROMISE Trial..
146:582-584.
2022
-
Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association..
146:e50-e68.
2022
-
Catastrophic Disruptions in Clinical Trials..
146:369-371.
2022
-
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial..
146:279-288.
2022
-
Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial..
146:80-90.
2022
-
Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants..
146:110-124.
2022
-
hapln1 Defines an Epicardial Cell Subpopulation Required for Cardiomyocyte Expansion During Heart Morphogenesis and Regeneration..
146:48-63.
2022
-
Evidence Builds for Catheter Ablation for Atrial Fibrillation and Heart Failure..
145:1705-1707.
2022
-
Cardiovascular Outcomes in Collegiate Athletes After SARS-CoV-2 Infection: 1-Year Follow-Up From the Outcomes Registry for Cardiac Conditions in Athletes..
145:1690-1692.
2022
-
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines..
145:e895-e1032.
2022
-
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines..
145:e876-e894.
2022
-
Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA..
145:1294-1307.
2022
-
Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization..
145:1205-1217.
2022
-
Prioritizing Quad Therapy and the Path Forward in Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction..
145:1105-1107.
2022
-
Equipoise in Clinical Trials: Enough Uncertainty in Whose Opinion?.
145:943-945.
2022
-
Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion..
145:896-905.
2022
-
Hemophagocytic Lymphohistiocytosis Associated With Endocarditis: A Case Years in the Making..
145:934-939.
2022
-
MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial..
145:906-915.
2022
-
Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial..
145:796-804.
2022
-
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium..
145:847-863.
2022
-
Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial..
145:819-828.
2022
-
Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial..
145:565-574.
2022
-
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association..
145:e153-e639.
2022
-
Sixth Annual Go Red for Women Issue..
145:489-490.
2022
-
Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination..
145:345-356.
2022
-
Perplexing Results From the PRAETORIAN Trial: Revisiting the Debate About the Value of Antitachycardia Pacing..
145:330-332.
2022
-
Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease..
145:357-370.
2022
-
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex..
145:242-255.
2022
-
Methodological Standards for the Design, Implementation, and Analysis of Randomized Trials in Cardiac Surgery: A Scientific Statement From the American Heart Association..
145:e129-e142.
2022
-
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines..
145:e18-e114.
2022
-
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines..
145:e4-e17.
2022
-
Bidirectional Changes in Myocardial 18F-Fluorodeoxyglucose Uptake After Human Ventricular Unloading..
145:151-154.
2022
-
Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial..
145:87-89.
2022
-
Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association..
144:e551-e563.
2021
-
Impact of the COVID-19 Pandemic on Cardiovascular Science: Anticipating Problems and Potential Solutions: A Presidential Advisory From the American Heart Association..
144:e461-e471.
2021
-
Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD..
144:1831-1841.
2021
-
Chest Pain Redux: Updated and Patient Centered..
144:1735-1737.
2021
-
Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review..
144:1646-1655.
2021
-
Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association..
144:e287-e305.
2021
-
Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA)..
144:1489-1499.
2021
-
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial..
144:1295-1307.
2021
-
Effects of Lifestyle Modification on Patients With Resistant Hypertension: Results of the TRIUMPH Randomized Clinical Trial..
144:1212-1226.
2021
-
Guidance for Timely and Appropriate Referral of Patients With Advanced Heart Failure: A Scientific Statement From the American Heart Association..
144:e238-e250.
2021
-
Cardiac Surgery in Women in the Current Era: What Are the Gaps in Care?.
144:1172-1185.
2021
-
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial..
144:1104-1116.
2021
-
Prognostication of Asymptomatic Penetrating Aortic Ulcers: A Modern Approach..
144:1091-1101.
2021
-
Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study..
144:1133-1144.
2021
-
Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study..
144:1008-1023.
2021
-
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity..
144:1024-1038.
2021
-
Novel Criteria for the Observe-Zone of the ESC 0/1h-hs-cTnT Algorithm..
144:773-787.
2021
-
Response by Shah et al to Letter Regarding Article, "Cell-Free DNA to Detect Heart Allograft Acute Rejection"..
144:e198-e199.
2021
-
PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the Heart..
144:712-727.
2021
-
Extending the Product Label for Ticagrelor: Looking Under the FDA Hood..
144:583-585.
2021
-
Myocarditis Temporally Associated With COVID-19 Vaccination..
144:502-505.
2021
-
Impact of High-Deductible Health Plans on Emergency Department Patients With Nonspecific Chest Pain and Their Subsequent Care..
144:336-349.
2021
-
SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes..
144:256-266.
2021
-
Composite Metric for Benchmarking Site Performance in Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry..
144:186-194.
2021
-
Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association..
144:e41-e55.
2021
-
Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF..
144:180-182.
2021
-
Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association..
144:e16-e35.
2021
-
Associations of Ideal Cardiovascular Health and Its Change During Young Adulthood With Premature Cardiovascular Events: A Nationwide Cohort Study..
144:90-92.
2021
-
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community..
144:74-84.
2021
-
2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report..
143:e1035-e1087.
2021
-
Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis..
143:2370-2383.
2021
-
Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association's COVID-19 Cardiovascular Disease Registry..
143:2332-2342.
2021
-
Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation..
143:2244-2253.
2021
-
Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results From the Transcatheter Valve Therapy Registry..
143:2229-2240.
2021
-
Response by Lopes et al to Letter Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial"..
143:e961-e962.
2021
-
Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association..
143:e836-e870.
2021
-
Transcatheter Closure of Patent Foramen Ovale: Not Always an "Open or Shut" Case..
143:1539-1541.
2021
-
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial..
143:1377-1390.
2021
-
Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients With Nonischemic Cardiomyopathy..
143:1343-1358.
2021
-
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial..
143:1215-1223.
2021
-
Cell-Free DNA to Detect Heart Allograft Acute Rejection..
143:1184-1197.
2021
-
Bench to Bedside Discovery, Innovation, Global Health Equity, and Security: A Conversation With Victor J. Dzau, MD..
143:1076-1080.
2021
-
Cardiovascular Consequences of Gestational Diabetes..
143:988-990.
2021
-
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association..
143:e254-e743.
2021
-
Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons..
143:790-804.
2021
-
Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results From the CABANA Trial..
143:661-672.
2021
-
Fifth Annual Go Red for Women Issue..
143:613-614.
2021
-
Temporal Trends in the Proportion of Women Physician Speakers at Major Cardiovascular Conferences..
143:755-757.
2021
-
Ten-Year Differences in Women's Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association..
143:e239-e248.
2021
-
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update..
143:583-596.
2021
-
Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Cardiac Magnetic Resonance Substudy Analysis..
143:606-608.
2021
-
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines..
143:e72-e227.
2021
-
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines..
143:e35-e71.
2021
-
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations..
143:479-500.
2021
-
Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop..
143:372-388.
2021
-
Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: The Heart and Kidney Working Better Together..
143:322-325.
2021
-
Response by Lee et al to Letter Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults"..
143:e22-e23.
2021
-
Be-All End-All Real-World Evidence on the Subcutaneous ICD..
143:18-20.
2021
-
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial..
143:7-17.
2021
-
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines..
142:e558-e631.
2020
-
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial..
142:2316-2328.
2020
-
Equipoise, Trust, and the Need for Cardiologists to Randomly Assign Patients Into Anticoagulation Trials in the Time of COVID..
142:2296-2298.
2020
-
Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety..
142:2219-2230.
2020
-
Prevention of Complications in the Cardiac Intensive Care Unit: A Scientific Statement From the American Heart Association..
142:e379-e406.
2020
-
Are We At Risk of Depriving Patients Lifesaving Cardiac Surgery?: Implications of the ISCHEMIA Trial for Coronary Artery Bypass Graft Surgery..
142:1797-1798.
2020
-
Assessing and Addressing Cardiovascular Health in LGBTQ Adults: A Scientific Statement From the American Heart Association..
142:e321-e332.
2020
-
Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study..
142:1810-1820.
2020
-
Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial..
142:1725-1735.
2020
-
Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction..
142:1532-1544.
2020
-
Part 6: Resuscitation Education Science: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care..
142:S551-S579.
2020
-
National Variation in Congenital Heart Surgery Outcomes..
142:1351-1360.
2020
-
Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization..
142:1205-1218.
2020
-
Built Environment Approaches to Increase Physical Activity: A Science Advisory From the American Heart Association..
142:e160-e166.
2020
-
Racial Differences in Serial NT-proBNP Levels in Heart Failure Management: Insights From the GUIDE-IT Trial..
142:1018-1020.
2020
-
The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering..
142:827-837.
2020
-
Challenges and Potential Improvements to Patient Access to Pharmaceuticals: Examples From Cardiology..
142:790-798.
2020
-
Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial..
142:717-719.
2020
-
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients..
142:621-642.
2020
-
Can an Old Ally Defeat a New Enemy?.
142:315-317.
2020
-
Rare Things Being Common: Implications for Common Genetic Variants in Rare Diseases Like Long-QT Syndrome..
142:339-341.
2020
-
β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19..
142:318-320.
2020
-
Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance..
142:230-243.
2020
-
Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic: AHA's Mission: Lifeline..
142:199-202.
2020
-
Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials..
142:150-160.
2020
-
Cardiovascular Health in American Indians and Alaska Natives: A Scientific Statement From the American Heart Association..
141:e948-e959.
2020
-
Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure: A Report From a US National Heart, Lung, and Blood Institute Virtual Workshop..
141:1915-1926.
2020
-
Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults..
141:1778-1786.
2020
-
Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure..
141:1800-1812.
2020
-
Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial..
141:1608-1617.
2020
-
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS..
141:1618-1627.
2020
-
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease..
141:1384-1392.
2020
-
Enhancing Cardiovascular Care: Global Collaboration Is How It Happens..
141:1357-1359.
2020
-
Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes..
141:1360-1370.
2020
-
Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity..
141:1318-1333.
2020
-
Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus..
141:1235-1237.
2020
-
Outcomes of Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve Disease: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry..
141:1071-1079.
2020
-
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies..
141:891-901.
2020
-
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions..
141:843-862.
2020
-
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association..
141:e139-e596.
2020
-
Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial..
141:781-783.
2020
-
Results of the FUEL Trial..
141:641-651.
2020
-
Effects of Exercise Therapy Dosing Schedule on Impaired Cardiorespiratory Fitness in Patients With Primary Breast Cancer: A Randomized Controlled Trial..
141:560-570.
2020
-
Fourth Annual Go Red for Women Issue..
141:499-500.
2020
-
The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk..
141:592-599.
2020
-
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition..
141:429-439.
2020
-
Research Needs and Priorities for Catheter Ablation of Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop..
141:482-492.
2020
-
Building the Foundation for a New Era of Quadruple Therapy in Heart Failure..
141:112-114.
2020
-
Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart Association..
141:e6-e32.
2020
-
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial..
141:10-20.
2020
-
Variation in Bystander Cardiopulmonary Resuscitation Delivery and Subsequent Survival From Out-of-Hospital Cardiac Arrest Based on Neighborhood-Level Ethnic Characteristics..
141:34-41.
2020
-
Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES..
140:2054-2062.
2019
-
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues..
140:2108-2118.
2019
-
Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis..
140:2076-2088.
2019
-
Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association..
140:e944-e963.
2019
-
Letter by Sniderman et al Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease"..
140:e822-e823.
2019
-
Prosthetic Valve Endocarditis After TAVR and SAVR: Insights From the PARTNER Trials..
140:1984-1994.
2019
-
Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician..
140:2019-2037.
2019
-
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial..
140:1921-1932.
2019
-
Coapting Cost and Clinical Outcomes in Transcatheter Intervention for Secondary Mitral Regurgitation..
140:1892-1894.
2019
-
Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial..
140:1960-1963.
2019
-
A Proposal for Modest Revision of the Definition of Type 1 and Type 2 Myocardial Infarction..
140:1773-1775.
2019
-
Anticoagulation-Related Major Bleeding in Patients With Atrial Fibrillation: Looking Behind the Curtain..
140:1802-1804.
2019
-
Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration..
140:1834-1850.
2019
-
Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury..
140:1661-1678.
2019
-
Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial..
140:1613-1622.
2019
-
Implantable Cardioverter-Defibrillators Have Stood the Test of Time!.
140:1540-1542.
2019
-
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes..
140:1578-1589.
2019
-
Addressing the Conundrum of Bleeding and Cancer Detection With Antithrombotic Therapies for Chronic Atherosclerotic Cardiovascular Disease..
140:1460-1462.
2019
-
Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports: Update of the Utstein Resuscitation Registry Template for In-Hospital Cardiac Arrest: A Consensus Report From a Task Force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia)..
140:e746-e757.
2019
-
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial..
140:1463-1476.
2019
-
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF..
140:1369-1379.
2019
-
Technology-Enabled Clinical Trials: Transforming Medical Evidence Generation..
140:1426-1436.
2019
-
Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease..
140:1115-1124.
2019
-
Letter by O'Neill and Ohman Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis"..
140:e557-e558.
2019
-
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
140:e382-e482.
2019
-
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society..
140:e333-e381.
2019
-
Acute Limb Ischemia in Peripheral Artery Disease..
140:556-565.
2019
-
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update..
140:e294-e324.
2019
-
Will Cardiac Intensive Care Unit Admissions Warrant Appropriate Use Criteria in the Future?.
140:267-269.
2019
-
Antibiotic Prophylaxis for Infective Endocarditis..
140:181-183.
2019
-
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention..
140:240-261.
2019
-
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons..
140:e125-e151.
2019
-
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association..
140:e98-e124.
2019
-
Effect of Alirocumab on Mortality After Acute Coronary Syndromes..
140:103-112.
2019
-
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
139:e1144-e1161.
2019
-
Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation..
139:2502-2512.
2019
-
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association..
139:e997-e1012.
2019
-
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight..
139:2292-2300.
2019
-
Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial..
139:2285-2288.
2019
-
Water Pipe (Hookah) Smoking and Cardiovascular Disease Risk: A Scientific Statement From the American Heart Association..
139:e917-e936.
2019
-
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease..
139:2170-2185.
2019
-
Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
139:e879-e886.
2019
-
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
139:e637-e697.
2019
-
Lin28a Regulates Pathological Cardiac Hypertrophic Growth Through Pck2-Mediated Enhancement of Anabolic Synthesis..
139:1725-1740.
2019
-
Quantifying Importance of Major Risk Factors for Coronary Heart Disease..
139:1603-1611.
2019
-
Use, Temporal Trends, and Outcomes of Endovascular Therapy After Interhospital Transfer in the United States..
139:1568-1577.
2019
-
Vascular Endothelial Growth Factor Receptor 3 Regulates Endothelial Function Through β-Arrestin 1..
139:1629-1642.
2019
-
Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable..
139:1497-1506.
2019
-
Association Between Sleep Apnea and Blood Pressure Control Among Blacks..
139:1275-1284.
2019
-
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association..
139:e56-e528.
2019
-
Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients..
139:1234-1236.
2019
-
Third Annual Go Red for Women Issue..
139:999-1000.
2019
-
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials..
139:863-873.
2019
-
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation..
139:787-798.
2019
-
Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding..
139:748-756.
2019
-
Influenza Vaccination in Patients With Heart Failure..
139:587-589.
2019
-
Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention..
139:458-472.
2019
-
Response by McCord et al to Letter Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction"..
139:564-565.
2019
-
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA..
139:351-361.
2019
-
Percutaneous Support Devices for Percutaneous Coronary Intervention..
139:347-350.
2019
-
A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke)..
139:192-205.
2019
-
Components and Trends in Door to Treatment Times for Endovascular Therapy in Get With The Guidelines-Stroke Hospitals..
139:169-179.
2019
-
Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus..
139:152-154.
2019
-
One-Year Outcomes After MitraClip for Functional Mitral Regurgitation..
139:37-47.
2019
-
Prevention of Cardiogenic Shock After Acute Myocardial Infarction..
139:137-139.
2019
-
Response by Friedman and Al-Khatib to Letter Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry"..
138:2972-2973.
2018
-
Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?.
138:2787-2797.
2018
-
Knowledge and Insights Vested in Us by the VEST..
138:2735-2737.
2018
-
Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease..
138:2576-2578.
2018
-
Response by Kumbhani et al to Letters Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure"..
138:2306-2307.
2018
-
Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?.
138:2145-2159.
2018
-
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study..
138:1923-1934.
2018
-
New Curveball for Hypertension Guidelines?.
138:1815-1818.
2018
-
Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
138:e595-e616.
2018
-
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation..
138:1666-1676.
2018
-
Twenty-Four-Hour Ambulatory Blood Pressure Reduction Patterns After Renal Denervation in the SPYRAL HTN-OFF MED Trial..
138:1602-1604.
2018
-
Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation..
138:1402-1411.
2018
-
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
138:e272-e391.
2018
-
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
138:e210-e271.
2018
-
Genetic Regulation of Fibroblast Activation and Proliferation in Cardiac Fibrosis..
138:1224-1235.
2018
-
Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure..
138:1039-1053.
2018
-
Left Atrial Appendage Closure: Two Steps Forward, One Step Back..
138:886-888.
2018
-
Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation..
138:889-897.
2018
-
Splanchnic Nerve Block for Acute Heart Failure..
138:951-953.
2018
-
Resuscitation Education Science: Educational Strategies to Improve Outcomes From Cardiac Arrest: A Scientific Statement From the American Heart Association..
138:e82-e122.
2018
-
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update..
138:527-536.
2018
-
Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction..
138:316-318.
2018
-
Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association..
138:e1-e34.
2018
-
Circulation Global Rounds..
138:10-11.
2018
-
Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): ARIC Study Community Surveillance..
138:12-24.
2018
-
Proteomic Architecture of Human Coronary and Aortic Atherosclerosis..
137:2741-2756.
2018
-
Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study..
137:2572-2582.
2018
-
Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists..
137:e843-e852.
2018
-
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document..
137:2635-2650.
2018
-
Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry..
137:2463-2477.
2018
-
Biased G Protein-Coupled Receptor Signaling: Changing the Paradigm of Drug Discovery..
137:2315-2317.
2018
-
Out-of-Hospital Cardiac Arrest Resuscitation Systems of Care: A Scientific Statement From the American Heart Association..
137:e645-e660.
2018
-
Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality..
137:2128-2138.
2018
-
Association Between Prompt Defibrillation and Epinephrine Treatment With Long-Term Survival After In-Hospital Cardiac Arrest..
137:2041-2051.
2018
-
Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association..
137:e523-e557.
2018
-
Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury..
137:2016-2028.
2018
-
Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure..
137:1661-1670.
2018
-
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)..
137:1571-1582.
2018
-
Ultrasound for Lower Extremity Deep Venous Thrombosis: Multidisciplinary Recommendations From the Society of Radiologists in Ultrasound Consensus Conference..
137:1505-1515.
2018
-
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association..
137:e67-e492.
2018
-
High-Sensitivity Troponin in Noncardiac Surgery: Pandora's Box or Opportunity for Precision Perioperative Care?.
137:1233-1235.
2018
-
Paving a Better Path for Patients Dying of Heart Disease..
137:1216-1217.
2018
-
Integrative Omics: Harnessing the Proteome to Maximize the Potential of the Genome..
137:1173-1175.
2018
-
Unmeasured Interface in Emergency Cardiovascular Care: How Do Dispatch-Assisted Telephone Cardiopulmonary Resuscitation and Bystander Training Interact?.
137:996-998.
2018
-
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials..
137:961-972.
2018
-
When VAD Things Happen to Good People..
137:907-909.
2018
-
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association..
137:e30-e66.
2018
-
Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization: Results From the STICH Trial (Surgical Treatment for Ischemic Heart Failure)..
137:771-780.
2018
-
Centers for Medicare and Medicaid Services' Decision to Reconsider Coverage Indications for ICDs: Where to Now?.
137:317-319.
2018
-
Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2..
137:376-387.
2018
-
Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl)..
137:307-309.
2018
-
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial)..
137:91-94.
2018
-
Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)..
136:2440-2450.
2017
-
Increase in Endovascular Therapy in Get With The Guidelines-Stroke After the Publication of Pivotal Trials..
136:2303-2310.
2017
-
Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry..
136:2132-2140.
2017
-
Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)..
136:1993-2005.
2017
-
Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey..
136:1860-1862.
2017
-
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age?.
136:1781-1783.
2017
-
High-Resolution Mapping of Chromatin Conformation in Cardiac Myocytes Reveals Structural Remodeling of the Epigenome in Heart Failure..
136:1613-1625.
2017
-
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association..
136:e232-e268.
2017
-
Recalibrating Reperfusion Waypoints..
136:1474-1476.
2017
-
Outcomes Associated With Extraction Versus Capping and Abandoning Pacing and Defibrillator Leads..
136:1387-1395.
2017
-
Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)..
136:1193-1203.
2017
-
What's in a Name? The New ICD-10 (10th Revision of the International Statistical Classification of Diseases and Related Health Problems) Codes and Type 2 Myocardial Infarction..
136:1180-1182.
2017
-
Transcription Factor RUNX1 Regulates Platelet PCTP (Phosphatidylcholine Transfer Protein): Implications for Cardiovascular Events: Differential Effects of RUNX1 Variants..
136:927-939.
2017
-
Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg..
136:798-812.
2017
-
Effect of Obesity and Underweight Status on Perioperative Outcomes of Congenital Heart Operations in Children, Adolescents, and Young Adults: An Analysis of Data From the Society of Thoracic Surgeons Database..
136:704-718.
2017
-
Leveraging Behavioral Economics to Improve Heart Failure Care and Outcomes..
136:765-772.
2017
-
Walking as a Window to Risk and Resiliency..
136:644-645.
2017
-
BAG3 (Bcl-2-Associated Athanogene-3) Coding Variant in Mice Determines Susceptibility to Ischemic Limb Muscle Myopathy by Directing Autophagy..
136:281-296.
2017
-
Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function..
136:65-79.
2017
-
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
135:e1159-e1195.
2017
-
Drone-Based Automatic External Defibrillators for Sudden Death? Do We Need More Courage or More Serenity?.
135:2466-2469.
2017
-
Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and Community Patient Care: A Scientific Statement From the American Heart Association..
135:e1145-e1158.
2017
-
Loss of Cardioprotective Effects at the ADAMTS7 Locus as a Result of Gene-Smoking Interactions..
135:2336-2353.
2017
-
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)..
135:2320-2332.
2017
-
Association of Feature-Tracking Cardiac Magnetic Resonance Imaging Left Ventricular Global Longitudinal Strain With All-Cause Mortality in Patients With Reduced Left Ventricular Ejection Fraction..
135:2313-2315.
2017
-
Composite End Points in Clinical Research: A Time for Reappraisal..
135:2299-2307.
2017
-
Response by Jones et al to Letter Regarding Article, "Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease"..
135:e1109-e1110.
2017
-
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association..
135:e1054-e1091.
2017
-
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure..
135:2003-2012.
2017
-
Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure)..
135:2077-2080.
2017
-
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration..
135:1851-1867.
2017
-
Engagement, Research, and Evidence: Leveraging the National Patient-Centered Clinical Research Network for Better Cardiovascular Health..
135:1478-1480.
2017
-
The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association..
135:e826-e857.
2017
-
Site Principal Investigators in Multicenter Clinical Trials: Appropriately Recognizing Key Contributors..
135:1185-1187.
2017
-
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
135:e726-e779.
2017
-
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
135:e686-e725.
2017
-
Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty"..
135:e785-e786.
2017
-
Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure)..
135:1136-1144.
2017
-
Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke..
135:1024-1035.
2017
-
Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association..
135:e604-e633.
2017
-
Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis..
135:1001-1003.
2017
-
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)..
135:648-655.
2017
-
Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Program"..
135:e22-e23.
2017
-
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease..
135:241-250.
2017
-
Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population..
135:128-139.
2017
-
Putting the Acute Coronary Syndrome in Context After 80 Years of Age..
135:5-6.
2017
-
Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction..
135:38-47.
2017
-
Improving Care of Out-of-Hospital Cardiac Arrest: Next Steps..
134:2040-2042.
2016
-
Resuscitation Science in Circulation: A Timely Topic..
134:2033-2034.
2016
-
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)..
134:1918-1930.
2016
-
Estimation of Risk for Initial Atherosclerotic Cardiovascular Disease Events: Taking Stock and Moving Forward..
134:1792-1793.
2016
-
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation..
134:1697-1707.
2016
-
Response by Fordyce et al to Letter Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF"..
134:e532-e533.
2016
-
The Dogged Search for Cryptic Effects of Ticagrelor: Wishful Thinking or Real Benefits Beyond P2Y12 Inhibition?.
134:1720-1723.
2016
-
Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy: A Report From the National Cardiovascular Data Registry..
134:1617-1628.
2016
-
Abstract 12670: Variability in Radiation Dose and Image Quality: A Comparison Across Fluoroscopy-system Vendors and Generations of Equipment..
134:A12670.
2016
-
Defibrillators: Selecting the Right Device for the Right Patient..
134:1390-1404.
2016
-
Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure)..
134:1314-1324.
2016
-
Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty..
134:1247-1256.
2016
-
Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling..
134:1122-1124.
2016
-
Medical Training to Achieve Competency in Lifestyle Counseling: An Essential Foundation for Prevention and Treatment of Cardiovascular Diseases and Other Chronic Medical Conditions: A Scientific Statement From the American Heart Association..
134:e308-e327.
2016
-
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery..
134:e123-e155.
2016
-
Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program..
134:517-526.
2016
-
Achieving the Full "PROMISE" of Imaging Outcomes Research..
134:359-361.
2016
-
Letter by Hess et al Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring"..
134:e28-e29.
2016
-
Regional Systems of Care Demonstration Project: American Heart Association Mission: Lifeline STEMI Systems Accelerator..
134:365-374.
2016
-
Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention..
134:422-431.
2016
-
The National Academy of Medicine and the Cardiovascular Community: Partnering for a Healthier Future..
134:183-185.
2016
-
Congenital Heart Disease Epidemiology in the United States: Blindly Feeling for the Charging Elephant..
134:110-113.
2016
-
One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis..
134:130-140.
2016
-
Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation"..
134:e7-e8.
2016
-
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF..
134:37-47.
2016
-
Regional Variation in Out-of-Hospital Cardiac Arrest Survival in the United States..
133:2159-2168.
2016
-
Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure..
133:2038-2049.
2016
-
Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society..
133:2103-2122.
2016
-
Quality-of-Life Outcomes With Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients With Suspected Coronary Artery Disease: Results From the PROMISE Randomized Trial..
133:1995-2007.
2016
-
Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial"..
133:e665.
2016
-
Evidence-Based Policy Making: Assessment of the American Heart Association's Strategic Policy Portfolio: A Policy Statement From the American Heart Association..
133:e615-e653.
2016
-
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association..
133:1715-1727.
2016
-
Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease..
133:1574-1581.
2016
-
Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical Trials..
133:1560-1573.
2016
-
Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association..
133:1520-1529.
2016
-
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
133:e506-e574.
2016
-
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
133:e471-e505.
2016
-
Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial..
133:1341-1350.
2016
-
Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
133:1426-1428.
2016
-
Gait Speed Predicts 30-Day Mortality After Transcatheter Aortic Valve Replacement: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry..
133:1351-1359.
2016
-
Report of the National Heart, Lung, and Blood Institute Working Group: An Integrated Network for Congenital Heart Disease Research..
133:1410-1418.
2016
-
Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
133:e575-e586.
2016
-
Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT"..
133:e463.
2016
-
Response to Letter Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans"..
133:e453.
2016
-
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions..
133:1135-1147.
2016
-
Swimming-Induced Pulmonary Edema: Pathophysiology and Risk Reduction With Sildenafil..
133:988-996.
2016
-
Good Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds..
133:872-880.
2016
-
The Failing Heart Relies on Ketone Bodies as a Fuel..
133:698-705.
2016
-
Surgery for Aortic Dilatation in Patients With Bicuspid Aortic Valves: A Statement of Clarification From the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
133:680-686.
2016
-
Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation..
133:352-360.
2016
-
Oral Anticoagulation in Patients with End Stage Renal Disease and Atrial Fibrillation: The Need to Evaluate Net Clinical Effect..
133:242-244.
2016
-
Association of Hospital and Physician Characteristics and Care Processes With Racial Disparities in Procedural Outcomes Among Contemporary Patients Undergoing Coronary Artery Bypass Grafting Surgery..
133:124-130.
2016
-
Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial..
133:131-138.
2016
-
Opportunities for the Cardiovascular Community in the Precision Medicine Initiative..
133:226-231.
2016
-
Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study..
133:156-164.
2016
-
Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial..
133:39-47.
2016
-
Characteristics and Survival of Malignant Cardiac Tumors: A 40-Year Analysis of >500 Patients..
132:2395-2402.
2015
-
The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease..
132:1999-2011.
2015
-
Ongoing Evolution of Outcomes Analysis for Pediatric and Congenital Cardiac Catheterization..
132:1853-1855.
2015
-
Part 6: Alternative Techniques and Ancillary Devices for Cardiopulmonary Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care..
132:S436-S443.
2015
-
Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans..
132:1538-1548.
2015
-
Response to Letter Regarding Article, "Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease"..
132:e203.
2015
-
Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study..
132:1404-1413.
2015
-
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association..
132:1435-1486.
2015
-
Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures..
132:1347-1353.
2015
-
Response to Letter Regarding Article, "Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis: A Prospective Study From the International Collaboration on Endocarditis"..
132:e184-e185.
2015
-
Understanding Population Cardiovascular Health: Harnessing the Power of Electronic Health Records..
132:1303-1304.
2015
-
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT..
132:1224-1233.
2015
-
Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association..
132:1157-1213.
2015
-
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry..
132:923-931.
2015
-
Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association..
132:852-872.
2015
-
Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial..
132:720-730.
2015
-
Task Force 8: Pediatric Cardiology Fellowship Training in Research and Scholarly Activity. SPCTPD/ACC/AAP/AHA..
132:e107-e113.
2015
-
Longitudinal Strain in Heart Failure With Preserved Ejection Fraction: Is There a Role for Prognostication?.
132:368-370.
2015
-
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)..
132:302-361.
2015
-
Response to Letters Regarding Article, "Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV"..
132:e29.
2015
-
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial..
132:27-39.
2015
-
Use of Appropriate Use Criteria Is Increasing, but What Are Their Effects on Medical Care?.
132:4-6.
2015
-
Circulating Exosomes Induced by Cardiac Pressure Overload Contain Functional Angiotensin II Type 1 Receptors..
131:2120-2130.
2015
-
Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy..
131:1989-2000.
2015
-
Response to letter regarding article, "Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry"..
131:e518.
2015
-
The National Physical Activity Plan: a call to action from the American Heart Association: a science advisory from the American Heart Association..
131:1932-1940.
2015
-
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study..
131:1763-1771.
2015
-
Hospital readmissions reduction program..
131:1796-1803.
2015
-
Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association..
131:1715-1736.
2015
-
Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension..
131:e435-e470.
2015
-
Hypertrophic preconditioning: short-term tricks for long-term gain..
131:1468-1470.
2015
-
Response to letters regarding article, "Cumulative radiation exposure and cancer risk estimation in children with heart disease"..
131:e419-e420.
2015
-
Back to the future: improving the use of guidelines-recommended coronary disease secondary prevention at the dawn of the precision medicine era..
131:1234-1235.
2015
-
Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association..
131:1123-1149.
2015
-
Doing the right things and doing them the right way: association between hospital guideline adherence, dosing safety, and outcomes among patients with acute coronary syndrome..
131:980-987.
2015
-
The heart is just a muscle..
131:914-922.
2015
-
Response to letter regarding article, "The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry"..
131:e358.
2015
-
What the dead can teach the living: systemic nature of heart failure with preserved ejection fraction..
131:522-524.
2015
-
Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease..
131:451-458.
2015
-
Mammoth ventricular hypertrophy..
131:e327-e329.
2015
-
Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)..
131:488-494.
2015
-
Executive summary: heart disease and stroke statistics-2015 update: a report from the american heart association..
131:434-441.
2015
-
Heart disease and stroke statistics--2015 update: a report from the American Heart Association..
131:e29-322.
2015
-
Phenomapping for novel classification of heart failure with preserved ejection fraction..
131:269-279.
2015
-
Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial..
131:254-262.
2015
-
Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis..
131:131-140.
2015
-
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction..
131:43-53.
2015
-
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines..
130:e344-e426.
2014
-
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines..
130:2354-2394.
2014
-
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines..
130:e278-e333.
2014
-
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines..
130:2215-2245.
2014
-
Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines..
130:2246-2264.
2014
-
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society..
130:e199-e267.
2014
-
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society..
130:2071-2104.
2014
-
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial..
130:1847-1858.
2014
-
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons..
130:1749-1767.
2014
-
Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV..
130:1445-1451.
2014
-
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation..
130:1225-1235.
2014
-
Challenges and priorities for research: a report from the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH) Working Group on thrombosis in pediatric cardiology and congenital heart disease..
130:1192-1203.
2014
-
ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up..
130:1139-1145.
2014
-
The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines..
130:1208-1217.
2014
-
Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry..
130:1037-1043.
2014
-
Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF)..
130:958-965.
2014
-
Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures..
130:S3-11.
2014
-
Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: an analysis from the society of thoracic surgeons adult cardiac database..
130:872-879.
2014
-
Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease..
130:668-675.
2014
-
Differences in short-term versus long-term outcomes of older black versus white patients with myocardial infarction: findings from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of American College of Cardiology/American Heart Association Guidelines (CRUSADE)..
130:659-667.
2014
-
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy..
130:484-495.
2014
-
Development of a clinical registry-based 30-day readmission measure for coronary artery bypass grafting surgery..
130:399-409.
2014
-
Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association..
130:350-379.
2014
-
Cumulative radiation exposure and cancer risk estimation in children with heart disease..
130:161-167.
2014
-
Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)..
130:138-146.
2014
-
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines..
129:S49-S73.
2014
-
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines..
129:S76-S99.
2014
-
ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee..
129:2578-2609.
2014
-
Gestational age at birth and outcomes after neonatal cardiac surgery: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database..
129:2511-2517.
2014
-
Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience..
129:2547-2556.
2014
-
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines..
129:e521-e643.
2014
-
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines..
129:2440-2492.
2014
-
ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards..
129:2346-2357.
2014
-
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines..
129:2329-2345.
2014
-
Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices..
129:2287-2296.
2014
-
Regression of cardiac amyloidosis after stem cell transplantation assessed by cardiovascular magnetic resonance imaging..
129:2326-2328.
2014
-
The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry..
129:2277-2286.
2014
-
A freeze on tailored antiplatelet therapy?.
129:2088-2090.
2014
-
Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry..
129:2005-2012.
2014
-
Impact of combat deployment and posttraumatic stress disorder on newly reported coronary heart disease among US active duty and reserve forces..
129:1813-1820.
2014
-
Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)..
129:1850-1859.
2014
-
Standardizing clinical end points in aortic arch surgery: a consensus statement from the International Aortic Arch Surgery Study Group..
129:1610-1616.
2014
-
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association..
129:1350-1369.
2014
-
A pint of sweat will save a gallon of blood: a call for randomized trials of anticoagulation in end-stage renal disease..
129:1190-1192.
2014
-
Decoding the noncoding transcripts in human heart failure..
129:958-960.
2014
-
Response to letter regarding article, "Emergency department bypass for ST-segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline Program"..
129:e372.
2014
-
ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association-Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance..
129:926-949.
2014
-
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial..
129:625-634.
2014
-
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association..
129:399-410.
2014
-
Heart disease and stroke statistics--2014 update: a report from the American Heart Association..
129:e28-e292.
2014
-
Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation"..
129:e21-e22.
2014
-
The devil is in the details: the need for integrated cardiovascular data for performance measures and feedback..
129:142-144.
2014
-
Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study..
129:42-50.
2014
-
Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A..
128:2776-2784.
2013
-
Temporal differences in out-of-hospital cardiac arrest incidence and survival..
128:2595-2602.
2013
-
High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice..
128:2364-2371.
2013
-
Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma..
128:2351-2363.
2013
-
Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association..
128:2422-2446.
2013
-
Synthesizing lessons learned from get with the guidelines: the value of disease-based registries in improving quality and outcomes..
128:2447-2460.
2013
-
Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association..
128:1927-1995.
2013
-
Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy..
128:1667-1674.
2013
-
Association of early physician follow-up and 30-day readmission after non-ST-segment-elevation myocardial infarction among older patients..
128:1206-1213.
2013
-
Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"..
128:e172-e173.
2013
-
Intervention for recoarctation in the single ventricle reconstruction trial: incidence, risk, and outcomes..
128:954-961.
2013
-
Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator..
128:944-953.
2013
-
Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel..
128:823-833.
2013
-
Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association..
128:762-773.
2013
-
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry..
128:721-728.
2013
-
Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease..
128:605-614.
2013
-
ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing committee to revise the 2007 clinical competence statement on cardiac interventional procedures)..
128:436-472.
2013
-
Emergency department bypass for ST-Segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline program..
128:352-359.
2013
-
Mechanism-based engineering against anthracycline cardiotoxicity..
128:98-100.
2013
-
Putting the vascular back into cardiovascular research: ST-segment-elevation myocardial infarction as a blueprint for improving care in patients with acute limb ischemia..
128:89-91.
2013
-
Response to letters regarding article, “Conversion of cardiovascular conference abstracts to publications”..
128:e29.
2013
-
Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis..
127:2316-2326.
2013
-
Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association..
127:2233-2249.
2013
-
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation..
127:2166-2176.
2013
-
Response to letter regarding article, “sustained ventricular tachycardia and ventricular fibrillation complicating non–ST-segment elevation acute coronary syndromes”..
127:e634.
2013
-
Divergent mitochondrial biogenesis responses in human cardiomyopathy..
127:1957-1967.
2013
-
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines..
127:1916-1926.
2013
-
Aorta-to-pulmonary vein fistula in an asymptomatic 25-year-old man..
127:1727-1729.
2013
-
Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database..
127:1647-1655.
2013
-
Strategies for improving survival after in-hospital cardiac arrest in the United States: 2013 consensus recommendations: a consensus statement from the American Heart Association..
127:1538-1563.
2013
-
Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases..
127:1395-1403.
2013
-
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
127:1425-1443.
2013
-
Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis..
127:1308-1316.
2013
-
Increasing cardiopulmonary resuscitation provision in communities with low bystander cardiopulmonary resuscitation rates: a science advisory from the American Heart Association for healthcare providers, policymakers, public health departments, and community leaders..
127:1342-1350.
2013
-
2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards)..
127:1052-1089.
2013
-
A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease..
127:730-738.
2013
-
Cost of ventricular assist devices: can we afford the progress?.
127:743-748.
2013
-
Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement..
127:749-756.
2013
-
The power of more than one..
127:665-667.
2013
-
The impact of a statewide pre-hospital STEMI strategy to bypass hospitals without percutaneous coronary intervention capability on treatment times..
127:604-612.
2013
-
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society..
127:e283-e352.
2013
-
Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge..
127:397-407.
2013
-
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
127:268-310.
2013
-
Approaches to the prevention and management of childhood obesity: the role of social networks and the use of social media and related electronic technologies: a scientific statement from the American Heart Association..
127:260-267.
2013
-
Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction..
127:213-223.
2013
-
Left ventricular support systems for high-risk percutaneous coronary interventions: how can we improve outcomes for rare procedures?.
127:162-164.
2013
-
Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts..
127:224-232.
2013
-
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association..
127:143-152.
2013
-
Heart disease and stroke statistics--2013 update: a report from the American Heart Association..
127:e6-e245.
2013
-
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons..
126:e354-e471.
2012
-
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons..
126:3097-3137.
2012
-
Conversion of cardiovascular conference abstracts to publications..
126:2819-2825.
2012
-
GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension..
126:2859-2869.
2012
-
Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues..
126:2749-2763.
2012
-
Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association..
126:2648-2667.
2012
-
Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States..
126:2293-2301.
2012
-
Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation..
126:2200-2207.
2012
-
Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort..
126:2190-2199.
2012
-
Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association..
126:2146-2172.
2012
-
Third universal definition of myocardial infarction..
126:2020-2035.
2012
-
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study..
126:1717-1727.
2012
-
Latency of ECG displays of hospital telemetry systems: a science advisory from the American Heart Association..
126:1665-1669.
2012
-
Long-term survival after aortic valve replacement among high-risk elderly patients in the United States: insights from the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 1991 to 2007..
126:1621-1629.
2012
-
Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association..
126:1514-1563.
2012
-
Evolution of critical care cardiology: transformation of the cardiovascular intensive care unit and the emerging need for new medical staffing and training models: a scientific statement from the American Heart Association..
126:1408-1428.
2012
-
Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains..
126:1345-1354.
2012
-
Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function..
126:1110-1120.
2012
-
Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association..
126:1143-1172.
2012
-
Anticoagulation, novel agents, and procedures: can we pardon the interruption?.
126:255-257.
2012
-
Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes: an international multicenter registry)..
126:304-313.
2012
-
Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality..
126:261-269.
2012
-
Expansion of a regional ST-segment-elevation myocardial infarction system to an entire state..
126:189-195.
2012
-
Letter by Cheung et al regarding article, "Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study"..
126:e13.
2012
-
Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes..
126:41-49.
2012
-
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes..
126:65-75.
2012
-
The Placement of Aortic Transcatheter Valve (PARTNER) trial: a health economic and policy perspective..
125:3243-3245.
2012
-
Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial..
125:2863-2872.
2012
-
Letter by goldstein regarding article, "statins and intracerebral hemorrhage"..
125:e1015.
2012
-
Prostaglandin E2 in remote control of myocardial remodeling..
125:2818-2820.
2012
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack..
125:2914-2921.
2012
-
When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure..
125:2948-2955.
2012
-
Does initial shunt type for the Norwood procedure affect echocardiographic measures of cardiac size and function during infancy?: the Single Vventricle Reconstruction trial..
125:2630-2638.
2012
-
Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial..
125:2639-2648.
2012
-
Recurrent inflammatory myofibroblastic tumor of the heart..
125:2379-2381.
2012
-
Early developmental outcome in children with hypoplastic left heart syndrome and related anomalies: the single ventricle reconstruction trial..
125:2081-2091.
2012
-
Decision making in advanced heart failure: a scientific statement from the American Heart Association..
125:1928-1952.
2012
-
Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance..
125:1858-1869.
2012
-
Association of bleeding and in-hospital mortality in black and white patients with st-segment-elevation myocardial infarction receiving reperfusion..
125:1727-1734.
2012
-
Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry..
125:1501-1510.
2012
-
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study)..
125:1491-1500.
2012
-
Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry..
125:1414-1423.
2012
-
Preoperative serum brain natriuretic peptide and risk of acute kidney injury after cardiac surgery..
125:1347-1355.
2012
-
Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents..
125:1276-1287.
2012
-
Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time?.
125:1094-1101.
2012
-
Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association..
125:1058-1072.
2012
-
Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery..
125:749-756.
2012
-
ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy..
125:514-521.
2012
-
Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry..
125:497-504.
2012
-
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease)..
125:395-467.
2012
-
Pulmonary capillary wedge pressure augments right ventricular pulsatile loading..
125:289-297.
2012
-
Rates of cardiac catheterization cancelation for ST-segment elevation myocardial infarction after activation by emergency medical services or emergency physicians: results from the North Carolina Catheterization Laboratory Activation Registry..
125:308-313.
2012
-
Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay..
125:14-22.
2012
-
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association..
125:188-197.
2012
-
Heart disease and stroke statistics--2012 update: a report from the American Heart Association..
125:e2-e220.
2012
-
Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism..
125:159-164.
2012
-
Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction..
124:2855-2864.
2011
-
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
124:e652-e735.
2011
-
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
124:2610-2642.
2011
-
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions..
124:e574-e651.
2011
-
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions..
124:2574-2609.
2011
-
ST-segment-elevation myocardial infarction treatment and the seductive lure of observational analyses..
124:2477-2479.
2011
-
Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction..
124:2320-2328.
2011
-
Improved cardiac risk assessment with noninvasive measures of coronary flow reserve..
124:2215-2224.
2011
-
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis..
124:2233-2242.
2011
-
ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures..
124:1483-1502.
2011
-
ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee..
124:1290-1310.
2011
-
Relationship of the time interval between cardiac catheterization and elective coronary artery bypass surgery with postprocedural acute kidney injury..
124:S149-S155.
2011
-
Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses..
124:S143-S148.
2011
-
Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry..
124:1028-1037.
2011
-
Socking It to cardiac hypertrophy: STIM1-mediated Ca2+ entry in the cardiomyocyte..
124:766-768.
2011
-
The need for regional integrated care for ST-segment elevation myocardial infarction..
124:851-856.
2011
-
The need for multiple measures of hospital quality: results from the Get with the Guidelines-Heart Failure Registry of the American Heart Association..
124:712-719.
2011
-
Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms..
124:642-650.
2011
-
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial..
124:544-554.
2011
-
American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association..
124:363-372.
2011
-
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial..
124:280-288.
2011
-
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement..
124:248-270.
2011
-
Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines..
124:154-163.
2011
-
ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards..
124:103-123.
2011
-
Cardiology Patient Page. Depression after heart attack: why should I be concerned about depression after a heart attack?.
123:e639-e640.
2011
-
Implementation strategies for improving survival after out-of-hospital cardiac arrest in the United States: consensus recommendations from the 2009 American Heart Association Cardiac Arrest Survival Summit..
123:2898-2910.
2011
-
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium..
123:2736-2747.
2011
-
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents..
123:2434-2506.
2011
-
Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle..
123:2353-2362.
2011
-
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
123:e426-e579.
2011
-
Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo..
123:1963-1973.
2011
-
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial..
123:1763-1770.
2011
-
Associations between outpatient heart failure process-of-care measures and mortality..
123:1601-1610.
2011
-
Response to letters regarding article, “Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy”..
123:e410-e411.
2011
-
Association of DASH diet with cardiovascular risk factors in youth with diabetes mellitus: the SEARCH for Diabetes in Youth study..
123:1410-1417.
2011
-
Pathological healing response of explanted MitraClip devices..
123:1418-1427.
2011
-
Percutaneous vascular stent implantation as treatment for central vascular obstruction due to fibrosing mediastinitis..
123:1391-1399.
2011
-
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association..
123:1243-1262.
2011
-
Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial..
123:1159-1166.
2011
-
Transcriptomic biomarkers for the accurate diagnosis of myocarditis..
123:1174-1184.
2011
-
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT)..
123:1061-1072.
2011
-
Disrupted junctional membrane complexes and hyperactive ryanodine receptors after acute junctophilin knockdown in mice..
123:979-988.
2011
-
Evaluating research in cardiovascular medicine: citation counts are not sufficient..
123:1038-1043.
2011
-
American Heart Association and nonprofit advocacy: past, present, and future. A policy recommendation from the American Heart Association..
123:816-832.
2011
-
Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels..
123:731-738.
2011
-
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes..
123:750-758.
2011
-
Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial..
123:722-730.
2011
-
Heart disease and stroke statistics--2011 update: a report from the American Heart Association..
123:e18-e209.
2011
-
Long-term outcome and impact of surgery on adults with coronary arteries originating from the opposite coronary cusp..
123:154-162.
2011
-
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
123:104-123.
2011
-
Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice..
123:39-45.
2011
-
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease)..
122:2583-2618.
2010
-
Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy..
122:2430-2440.
2010
-
Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy..
122:2441-2449.
2010
-
Myocardial infarction and risk of suicide: another reason to develop and test ways to reduce distress in postmyocardial-infarction patients?.
122:2356-2358.
2010
-
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance..
122:e525-e555.
2010
-
Corticosteroids and outcome in children undergoing congenital heart surgery: analysis of the Pediatric Health Information Systems database..
122:2123-2130.
2010
-
Ionizing radiation exposure to patients admitted with acute myocardial infarction in the United States..
122:2160-2169.
2010
-
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis..
122:2131-2141.
2010
-
ACCF/AHA new insights into the methodology of performance measurement: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures..
122:2091-2106.
2010
-
Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface..
122:2068-2077.
2010
-
Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association..
122:1882-1893.
2010
-
Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association..
122:1756-1776.
2010
-
Letter by Hill et al. regarding article, "Mortality in first 5 years in infants with functional single ventricle born in Texas, 1996 to 2003"..
122:e491.
2010
-
Moving care forward: prehospital emergency cardiac systems..
122:1443-1445.
2010
-
Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program..
122:1496-1504.
2010
-
Selecting a noninvasive imaging study after an inconclusive exercise test..
122:1514-1518.
2010
-
Letter by Gurbel et al regarding article, "Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement"..
122:e478.
2010
-
AACVPR/ACCF/AHA 2010 update: performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services: a report of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Clinical Performance Measures for Cardiac Rehabilitation)..
122:1342-1350.
2010
-
Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries..
122:1167-1175.
2010
-
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia..
122:1144-1152.
2010
-
First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention..
122:614-622.
2010
-
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)..
122:585-596.
2010
-
Enalapril in infants with single ventricle: results of a multicenter randomized trial..
122:333-340.
2010
-
Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association..
122:406-441.
2010
-
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents..
121:2509-2543.
2010
-
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents..
121:2462-2508.
2010
-
Reducing consumption of sugar-sweetened beverages is associated with reduced blood pressure: a prospective study among United States adults..
121:2398-2406.
2010
-
Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program..
121:2294-2301.
2010
-
Acute kidney injury and cardiovascular outcomes in acute severe hypertension..
121:2183-2191.
2010
-
Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart..
121:1912-1925.
2010
-
Minimizing the risks of anticoagulants and platelet inhibitors..
121:1960-1970.
2010
-
ACCF/AHA 2010 Position Statement on Composite Measures for Healthcare Performance Assessment: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to develop a position statement on composite measures)..
121:1780-1791.
2010
-
Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial..
121:1713-1721.
2010
-
Medication errors in acute cardiovascular and stroke patients: a scientific statement from the American Heart Association..
121:1664-1682.
2010
-
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria..
121:1533-1541.
2010
-
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group..
121:1447-1454.
2010
-
Global chronic disease research training for fellows: perspectives, challenges, and opportunities..
121:1365-1370.
2010
-
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study..
121:1188-1199.
2010
-
Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias..
121:1005-1013.
2010
-
Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy..
121:853-862.
2010
-
Delivery of glycoprotein IIb/IIIa inhibitor therapy for percutaneous coronary intervention: why not take the intracoronary highway?.
121:739-741.
2010
-
Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (ICE) Trial..
121:784-791.
2010
-
Analysis of ventricular activation using surface electrocardiography to predict left ventricular reverse volumetric remodeling during cardiac resynchronization therapy..
121:626-634.
2010
-
Arterial stiffness and cardiovascular events: the Framingham Heart Study..
121:505-511.
2010
-
Combination antithrombotic therapies..
121:569-583.
2010
-
Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry..
121:357-365.
2010
-
Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community..
121:200-207.
2010
-
Too much, too little, or just right?: untangling endogenous erythropoietin in heart failure..
121:191-193.
2010
-
Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure..
121:34-42.
2010
-
Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial..
121:43-51.
2010
-
Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries..
121:63-70.
2010
-
Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms..
121:52-62.
2010
-
Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study..
120:2577-2585.
2009
-
Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community..
120:2414-2420.
2009
-
Inhibitors of platelet adhesion..
120:2488-2495.
2009
-
Helmut Drexler, MD, 1951-2009..
120:2402-2403.
2009
-
Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device..
120:2352-2357.
2009
-
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial..
120:2170-2176.
2009
-
Detection of myocardial damage in patients with sarcoidosis..
120:1969-1977.
2009
-
AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research..
120:1296-1336.
2009
-
Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy..
120:1248-1254.
2009
-
State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association..
120:1141-1163.
2009
-
Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures..
120:S215-S219.
2009
-
Prevalence and variability of internal mammary artery graft use in contemporary multivessel coronary artery bypass graft surgery: analysis of the Society of Thoracic Surgeons National Cardiac Database..
120:935-940.
2009
-
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population..
120:835-842.
2009
-
Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program..
120:560-567.
2009
-
Electrocardiographic features of arrhythmogenic right ventricular dysplasia..
120:477-487.
2009
-
Macrovolt T-wave alternans and polymorphic ventricular tachycardia..
120:445-446.
2009
-
Assays for S-nitrosothiols and S-nitrosylated proteins and mechanistic insights into cardioprotection..
120:190-193.
2009
-
Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study..
120:212-220.
2009
-
Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction..
119:3110-3117.
2009
-
Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study..
119:3085-3092.
2009
-
Predicting the 30-year risk of cardiovascular disease: the framingham heart study..
119:3078-3084.
2009
-
Recommendations for clinical exercise laboratories: a scientific statement from the american heart association..
119:3144-3161.
2009
-
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial..
119:2877-2885.
2009
-
Careers for clinician investigators..
119:2945-2950.
2009
-
The American Heart Association's principles for comparative effectiveness research: a policy statement from the American Heart Association..
119:2955-2962.
2009
-
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease..
119:2545-2552.
2009
-
Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice..
119:2454-2462.
2009
-
The complex relationship between cholesterol and brain hemorrhage..
119:2131-2133.
2009
-
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score..
119:1873-1882.
2009
-
Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion..
119:1736-1746.
2009
-
Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005..
119:1728-1735.
2009
-
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial..
119:1616-1624.
2009
-
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography..
119:1330-1352.
2009
-
Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction..
119:1293-1303.
2009
-
Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community..
119:1101-1107.
2009
-
Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial..
119:969-977.
2009
-
Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial..
119:687-698.
2009
-
Framework for patient safety research and improvement..
119:330-337.
2009
-
ACCF/ACR/AHA/ASE/ASNC/HRS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR 2008 Health Policy Statement on Structured Reporting in Cardiovascular Imaging. Endorsed by the Society of Nuclear Medicine [added]..
119:187-200.
2009
-
Atherosclerotic Peripheral Vascular Disease Symposium II: vascular magnetic resonance and computed tomographic imaging..
118:2837-2844.
2008
-
Sex differences in medical care and early death after acute myocardial infarction..
118:2803-2810.
2008
-
ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine..
118:2596-2648.
2008
-
ACC/AHA 2008 statement on performance measurement and reperfusion therapy: a report of the ACC/AHA Task Force on Performance Measures (Work Group to address the challenges of performance measurement and reperfusion therapy)..
118:2649-2661.
2008
-
ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures..
118:2662-2666.
2008
-
Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death..
118:2540-2549.
2008
-
ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease)..
118:2395-2451.
2008
-
ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease)..
118:e714-e833.
2008
-
Hypercoagulable states in cardiovascular disease..
118:2286-2297.
2008
-
Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding..
118:2139-2145.
2008
-
The American Heart Association's 2008 Statement of Principles for Healthcare Reform..
118:2209-2218.
2008
-
Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells..
118:2156-2165.
2008
-
Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials..
118:2038-2046.
2008
-
Long-term trends in the incidence of heart failure after myocardial infarction..
118:2057-2062.
2008
-
Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy..
118:2022-2028.
2008
-
Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research and the American College of Cardiology Foundation..
118:1885-1893.
2008
-
Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association..
118:1768-1775.
2008
-
Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery..
118:1619-1625.
2008
-
Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database..
118:S83-S88.
2008
-
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial..
118:1335-1346.
2008
-
Use of cardiac resynchronization therapy in patients hospitalized with heart failure..
118:926-933.
2008
-
Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry..
118:632-638.
2008
-
What do you need to know before performing a percutaneous coronary intervention?.
118:609-611.
2008
-
Evidence of arteriolar narrowing in low-birth-weight children..
118:518-524.
2008
-
Recent accreditation council for graduate medical education initiatives have not been shown to improve the education of cardiology fellows..
118:532-537.
2008
-
Transcriptomic biomarkers for individual risk assessment in new-onset heart failure..
118:238-246.
2008
-
Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy..
117:3070-3078.
2008
-
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease..
117:2865-2874.
2008
-
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons..
117:e350-e408.
2008
-
Embolic protection and platelet inhibition during renal artery stenting..
117:2752-2760.
2008
-
Impact of time of presentation on the care and outcomes of acute myocardial infarction..
117:2502-2509.
2008
-
Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group..
117:2544-2565.
2008
-
Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents..
117:2071-2078.
2008
-
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry..
117:1787-1801.
2008
-
Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology..
117:1897-1907.
2008
-
Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial..
117:1518-1525.
2008
-
ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance: endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine..
117:1478-1497.
2008
-
A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemia..
117:1207-1215.
2008
-
ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society..
117:1101-1120.
2008
-
Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the Society of Thoracic Surgeons National Cardiac Database..
117:876-885.
2008
-
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction..
117:886-896.
2008
-
General cardiovascular risk profile for use in primary care: the Framingham Heart Study..
117:743-753.
2008
-
Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial..
117:629-637.
2008
-
Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) trial..
117:553-559.
2008
-
Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia..
117:526-535.
2008
-
Vitamin D deficiency and risk of cardiovascular disease..
117:503-511.
2008
-
Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery..
117:356-362.
2008
-
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee..
117:296-329.
2008
-
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy..
117:192-199.
2008
-
Exploring the behavior of hospital composite performance measures: an example from coronary artery bypass surgery..
116:2969-2975.
2007
-
Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?.
116:2793-2801.
2007
-
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial..
116:2669-2677.
2007
-
Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure..
116:2571-2579.
2007
-
Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function..
116:2325-2345.
2007
-
Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling..
116:2127-2138.
2007
-
Acute ischemic stroke treatment in 2007..
116:1504-1514.
2007
-
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure..
116:1482-1487.
2007
-
Mitogen-activated protein kinases in heart development and diseases..
116:1413-1423.
2007
-
ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training: developed in collaboration with the Society of Atherosclerosis Imaging and Prevention, the Society for Cardiovascular Angiography and Interventions, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine and Biology..
116:1318-1335.
2007
-
Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes..
116:1153-1161.
2007
-
Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization..
116:1145-1152.
2007
-
Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study..
116:984-992.
2007
-
Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack..
116:928-935.
2007
-
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine..
116:e148-e304.
2007
-
A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database..
116:606-612.
2007
-
Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program..
116:627-636.
2007
-
Gi alpha 1-mediated cardiac electrophysiological remodeling and arrhythmia in hypertrophic cardiomyopathy..
116:596-605.
2007
-
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure..
116:e99-109.
2007
-
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection..
116:497-505.
2007
-
Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference?.
116:293-297.
2007
-
Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements..
116:174-179.
2007
-
Development of systems of care for ST-elevation myocardial infarction patients: evaluation and outcomes..
116:e64-e67.
2007
-
Development of systems of care for ST-elevation myocardial infarction patients: gaps, barriers, and implications..
116:e68-e72.
2007
-
Development of systems of care for ST-elevation myocardial infarction patients: the primary percutaneous coronary intervention (ST-elevation myocardial infarction-receiving) hospital perspective..
116:e55-e59.
2007
-
Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)..
116:151-157.
2007
-
ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures)..
116:98-124.
2007
-
Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study..
115:3156-3164.
2007
-
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program..
115:3111-3120.
2007
-
Added benefit of mineralocorticoid receptor blockade in the primary prevention of sudden cardiac death..
115:2976-2982.
2007
-
Drug-eluting stents "deliver heartburn": how do we spell relief going forward?.
115:2990-2994.
2007
-
Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention..
115:2761-2788.
2007
-
Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial..
115:2642-2651.
2007
-
Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)..
115:2637-2641.
2007
-
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology..
115:2549-2569.
2007
-
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology..
115:2570-2589.
2007
-
Clinical end points in coronary stent trials: a case for standardized definitions..
115:2344-2351.
2007
-
Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction..
115:2006-2014.
2007
-
Adult congenital heart disease: right ventricular outflow tract lesions..
115:1933-1947.
2007
-
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes..
115:e356-e375.
2007
-
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes..
115:e352-e355.
2007
-
The Fontan right atrium--in context..
115:1698-1700.
2007
-
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases..
115:1659-1662.
2007
-
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases..
115:1656-1695.
2007
-
Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study..
115:1544-1550.
2007
-
Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation..
115:1643-1455.
2007
-
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update..
115:1481-1501.
2007
-
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome..
115:962-971.
2007
-
Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation..
115:881-887.
2007
-
Risk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertension..
115:733-742.
2007
-
Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group..
115:658-676.
2007
-
Rapid detection of myocardial infarction by subsecond, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance..
115:236-244.
2007
-
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease)..
114:2850-2870.
2006
-
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions..
114:2871-2891.
2006
-
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity..
114:2490-2497.
2006
-
Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?.
114:2432-2433.
2006
-
Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon..
114:2325-2333.
2006
-
The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy..
114:2313-2316.
2006
-
Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery..
114:2208-2216.
2006
-
Contemporary impact of state certificate-of-need regulations for cardiac surgery: an analysis using the Society of Thoracic Surgeons' National Cardiac Surgery Database..
114:2122-2129.
2006
-
Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction..
114:2138-2147.
2006
-
Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology..
114:1761-1791.
2006
-
Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative..
114:1380-1387.
2006
-
Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks..
114:974-984.
2006
-
Letter by Bourque et al regarding article, "Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994"..
114:e255.
2006
-
Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice..
114:404-413.
2006
-
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial..
114:281-288.
2006
-
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)..
114:135-142.
2006
-
Images in cardiovascular medicine: in vivo imaging of the adult Drosophila melanogaster heart with real-time optical coherence tomography..
114:e35-e36.
2006
-
Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data..
114:11-17.
2006
-
High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients..
114:I344-I349.
2006
-
Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft..
114:I396-I401.
2006
-
Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery..
114:I275-I281.
2006
-
Long-term outcomes of the symmetry vein graft anastomosis device: a matched case-control analysis..
114:I425-I429.
2006
-
Low-dose dobutamine tissue-tagged magnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy..
114:I33-I36.
2006
-
Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation..
114:I27-I32.
2006
-
Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study..
113:2914-2918.
2006
-
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group..
113:e873-e923.
2006
-
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure..
113:2572-2578.
2006
-
Heart failure during cardiac pacing..
113:2082-2088.
2006
-
Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2..
113:1641-1649.
2006
-
Acute myocardial infarction in pregnancy: a United States population-based study..
113:1564-1571.
2006
-
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22..
113:1406-1414.
2006
-
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline..
113:e409-e449.
2006
-
Images in cardiovascular medicine. Untreated tetralogy of Fallot with pulmonary atresia: giant aneurysm of an aortopulmonary collateral artery demonstrated by magnetic resonance imaging..
113:e293-e294.
2006
-
Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database..
113:1063-1070.
2006
-
Relationship of patient and medical characteristics to health status in children and adolescents after the Fontan procedure..
113:1123-1129.
2006
-
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program..
113:986-994.
2006
-
Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?.
113:776-782.
2006
-
Coming together to achieve quality cardiovascular care..
113:607-608.
2006
-
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure..
113:671-678.
2006
-
Images in cardiovascular medicine. Noninvasive characterization of left atrial mass..
113:e19-e20.
2006
-
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease..
113:203-212.
2006
-
Arrhythmogenic right ventricular dysplasia: a United States experience..
112:3823-3832.
2005
-
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients..
112:3738-3744.
2005
-
Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution..
112:3328-3336.
2005
-
Atherosclerosis 2005: recent discoveries and novel hypotheses..
112:3348-3353.
2005
-
Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy..
112:3140-3148.
2005
-
Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry..
112:3049-3057.
2005
-
Cardiology patient page. Heart attack and stroke prevention in women..
112:e273-e275.
2005
-
Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure..
112:1719-1727.
2005
-
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction..
112:1451-1461.
2005
-
Clinical predictors of major infections after cardiac surgery..
112:I358-I365.
2005
-
Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting..
112:I293-I298.
2005
-
Risk-adjusted short- and long-term outcomes for on-pump versus off-pump coronary artery bypass surgery..
112:I366-I370.
2005
-
Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure..
112:48-53.
2005
-
Frontiers in cardiovascular magnetic resonance..
112:135-144.
2005
-
Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America..
111:e394-e434.
2005
-
Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers..
111:2699-2710.
2005
-
Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex..
111:2579-2587.
2005
-
Association of prolonged QRS duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction..
111:2418-2423.
2005
-
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study..
111:2454-2460.
2005
-
p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart..
111:2494-2502.
2005
-
Atherothrombotic disorders: new insights from hematology..
111:1855-1863.
2005
-
Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial..
111:1611-1618.
2005
-
Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial..
111:1390-1397.
2005
-
Influence of racial disparities in procedure use on functional status outcomes among patients with coronary artery disease..
111:1284-1290.
2005
-
Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?)..
111:1225-1232.
2005
-
Relationship between race and mortality and morbidity after valve replacement surgery..
111:1305-1312.
2005
-
The cardiovascular state of the union: confronting healthcare disparities..
111:1205-1207.
2005
-
Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study..
111:1153-1159.
2005
-
Noninvasive assessment of blood flow based on magnetic resonance global coherent free precession..
111:1033-1039.
2005
-
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems..
111:1078-1091.
2005
-
Level of beta-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure..
111:591-597.
2005
-
Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction..
111:165-172.
2005
-
Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion..
110:e533-e539.
2004
-
Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator..
110:3760-3765.
2004
-
Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator..
110:3646-3654.
2004
-
Lessons learned from a clinical trial..
110:3610-3614.
2004
-
Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure..
110:3518-3526.
2004
-
Fixing the heart: must the brain pay the price?.
110:3402-3403.
2004
-
Prognostic value of anxiety and depression in patients with chronic heart failure..
110:3452-3456.
2004
-
Left atrial tachycardia originating from the mitral annulus-aorta junction..
110:3187-3192.
2004
-
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?.
110:3281-3288.
2004
-
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials..
110:2618-2626.
2004
-
Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses..
110:2721-2746.
2004
-
ACCF/AHA consensus conference report on professionalism and ethics..
110:2506-2549.
2004
-
Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia..
110:2467-2475.
2004
-
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program..
110:2180-2183.
2004
-
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries..
110:2039-2046.
2004
-
Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease..
110:1960-1966.
2004
-
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I..
110:1754-1760.
2004
-
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial..
110:1572-1578.
2004
-
Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation..
110:1645-1649.
2004
-
Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial..
110:1598-1604.
2004
-
Single versus multiple internal mammary artery grafting for coronary artery bypass: 15-year follow-up of a clinical practice trial..
110:II27-II35.
2004
-
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)..
110:e82-292.
2004
-
Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial..
110:766-769.
2004
-
Is the impact of hospital and surgeon volumes on the in-hospital mortality rate for coronary artery bypass graft surgery limited to patients at high risk?.
110:784-789.
2004
-
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)..
110:588-636.
2004
-
Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity..
110:58-65.
2004
-
Genetic markers: progress and potential for cardiovascular disease..
109:IV47-IV58.
2004
-
Markers of malign across the cardiovascular continuum: interpretation and application..
109:IV1-IV2.
2004
-
Risk factor criteria..
109:IV3-IV5.
2004
-
The benefit of prevention: engaging the public through strategic collaborations..
109:3062-6063.
2004
-
Atherosclerotic Vascular Disease Conference: Writing Group IV: imaging..
109:2626-2633.
2004
-
The clinician as investigator: participating in clinical trials in the practice setting..
109:2672-2679.
2004
-
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design..
109:e302-e304.
2004
-
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis..
109:e305-e307.
2004
-
Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine?.
109:2476-2479.
2004
-
Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism..
109:2386-2393.
2004
-
Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study..
109:1973-1980.
2004
-
Early predictors of in-hospital death in infective endocarditis..
109:1745-1749.
2004
-
Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells..
109:1769-1775.
2004
-
National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report..
109:1697-1703.
2004
-
Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts..
109:1590-1593.
2004
-
Choosing between percutaneous coronary intervention and coronary artery bypass grafting for patients with multivessel disease: what can we learn from the Arterial Revascularization Therapy Study (ARTS)?.
109:1079-1081.
2004
-
Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification..
109:990-996.
2004
-
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study..
109:1004-1009.
2004
-
Cardiovascular disease in women: are there solutions?.
109:561.
2004
-
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods..
109:641-646.
2004
-
Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance..
109:166-171.
2004
-
Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes..
109:262-268.
2004
-
Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial..
108:2857-2863.
2003
-
Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia..
108:2805-2811.
2003
-
Images in cardiovascular medicine. Approaching cardiac development in three dimensions by magnetic resonance microscopy..
108:e154-e155.
2003
-
Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction..
108:2769-2775.
2003
-
Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart: application to study of phospholamban physiology..
108:2790-2797.
2003
-
Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy..
108:2710-2715.
2003
-
Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy..
108:1945-1953.
2003
-
Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness..
108:1845-1851.
2003
-
Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo..
108:1611-1618.
2003
-
Exercise capacity: the prognostic variable that doesn't get enough respect..
108:1534-1536.
2003
-
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial..
108:1316-1323.
2003
-
Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells..
108 Suppl 1:II264-II271.
2003
-
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial..
108:1176-1183.
2003
-
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial..
108:1184-1190.
2003
-
Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation..
108 Suppl 1:II103-II110.
2003
-
Topical VEGF enhances healing of thoracic aortic anastomosis for coarctation in a rabbit model..
108 Suppl 1:II150-II154.
2003
-
A20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosis..
108:1113-1118.
2003
-
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography)..
108:1146-1162.
2003
-
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy..
108:939-944.
2003
-
Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock..
108:951-957.
2003
-
Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice..
108:754-759.
2003
-
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease..
108:399-406.
2003
-
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy..
108:275-281.
2003
-
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction..
108:135-142.
2003
-
Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks..
108:67-72.
2003
-
Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis..
108:73-78.
2003
-
Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction..
107:2932-2937.
2003
-
Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity..
107:2908-2913.
2003
-
Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003..
107:e9052.
2003
-
Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling..
107:2857-2863.
2003
-
Fibrinolysis for acute myocardial infarction: the future is here and now..
107:2533-2537.
2003
-
Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database..
107:1864-1870.
2003
-
Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)..
107:1614-1619.
2003
-
American College of Cardiology/American Heart Association clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians--American Society of Internal Medicine Task Force on Clinical Competence..
107:1068-1089.
2003
-
Validity of a simple ST-elevation acute myocardial infarction risk index: are randomized trial prognostic estimates generalizable to elderly patients?.
107:811-816.
2003
-
American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science..
107:645-651.
2003
-
Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial..
107:437-442.
2003
-
Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure..
107:223-225.
2003
-
Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003..
107:e9002-e9003.
2003
-
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide..
107:238-244.
2003
-
Diets and clinical coronary events: the truth is out there..
107:10-16.
2003
-
Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT)..
106:2694-2699.
2002
-
Coronary artery pattern and outcome of arterial switch operation for transposition of the great arteries: a meta-analysis..
106:2575-2580.
2002
-
Medication errors in acute cardiac care: An American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and Council on Stroke..
106:2623-2629.
2002
-
Task Force on Strategic Research Direction: Basic Science Subgroup key science topics report..
106:e149-e161.
2002
-
Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial..
106:2466-2472.
2002
-
Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging..
106:2322-2327.
2002
-
ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines)..
106:1883-1892.
2002
-
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide..
106:1470-1476.
2002
-
Clinical assessment of atherosclerotic lesions: emerging from angiographic shadows..
106:1308-1309.
2002
-
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial..
106:1243-1250.
2002
-
Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes..
106:974-980.
2002
-
Anticoagulant responses to thrombin are enhanced during regression of atherosclerosis in monkeys..
106:842-846.
2002
-
Intracoronary brachytherapy: time to sell short?.
106:646-648.
2002
-
Medical economics and the assessment of value in cardiovascular medicine: Part II..
106:626-630.
2002
-
Medical economics and the assessment of value in cardiovascular medicine: Part I..
106:516-520.
2002
-
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee..
106:388-391.
2002
-
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes..
106:309-312.
2002
-
Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial..
106:233-238.
2002
-
Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging..
106:e6.
2002
-
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation..
105:2385-2391.
2002
-
Calcineurin signaling in human cardiac hypertrophy..
105:2242-2243.
2002
-
Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein..
105:1879-1882.
2002
-
Losartan potassium (Cozaar)..
105:e9100.
2002
-
Genetic modifier loci affecting survival and cardiac function in murine dilated cardiomyopathy..
105:1824-1829.
2002
-
Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease..
105:1686-1692.
2002
-
Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk..
105:1663-1668.
2002
-
Images in cardiovascular medicine. Left ventricular apical pseudoaneurysm: echocardiographic and intraoperative findings..
105:e51-e52.
2002
-
Conservative management of acute coronary syndrome: cheaper and better for you?.
105:666-668.
2002
-
Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene..
105:602-607.
2002
-
Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?.
105:554-556.
2002
-
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial..
105:322-327.
2002
-
Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury..
105:224-229.
2002
-
Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress..
105:85-92.
2002
-
Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease..
105:32-40.
2002
-
Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial..
104:2772-2777.
2001
-
Protection against oxidized low-density lipoprotein-induced vascular endothelial cell death by integrin-linked kinase..
104:2762-2766.
2001
-
Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction..
104:2641-2644.
2001
-
Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial..
104:2653-2659.
2001
-
Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice..
104:2485-2491.
2001
-
Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning..
104:2453-2458.
2001
-
Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging..
104:2412-2416.
2001
-
Depression, heart rate variability, and acute myocardial infarction..
104:2024-2028.
2001
-
In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein..
104:2088-2094.
2001
-
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials..
104:1229-1235.
2001
-
Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function..
104:1101-1107.
2001
-
Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators..
104:1029-1033.
2001
-
Abciximab readministration: results of the ReoPro Readministration Registry..
104:870-875.
2001
-
Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention..
104:406-411.
2001
-
Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction..
104:436-441.
2001
-
Cardiac gene delivery with cardiopulmonary bypass..
104:131-133.
2001
-
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy..
103:2891-2896.
2001
-
Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 2..
103:2987-2992.
2001
-
Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1..
103:2862-2866.
2001
-
Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation..
103:2780-2783.
2001
-
Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation..
103:2731-2738.
2001
-
Therapeutic potential of nitric oxide synthase gene manipulation..
103:2760-2765.
2001
-
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study..
103:2572-2578.
2001
-
Sex differences in neurological outcomes and mortality after cardiac surgery: a society of thoracic surgery national database report..
103:2133-2137.
2001
-
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia..
103:1838-1843.
2001
-
Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study..
103:1832-1837.
2001
-
Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes..
103:1727-1733.
2001
-
Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload..
103:1453-1458.
2001
-
Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation..
103:E60.
2001
-
In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction..
103:1311-1316.
2001
-
Bolus fibrinolysis: risk, benefit, and opportunities..
103:1171-1173.
2001
-
Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies..
103:954-960.
2001
-
Three-dimensional images of coronary arteries after heart transplantation using electron-beam computed tomography data with volume rendering..
103:E25-E26.
2001
-
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association..
103:163-182.
2001
-
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade..
102:2923-2929.
2000
-
Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators..
102:2952-2958.
2000
-
Physiological induction of a beta-adrenergic receptor kinase inhibitor transgene preserves ss-adrenergic responsiveness in pressure-overload cardiac hypertrophy..
102:2751-2757.
2000
-
Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000)..
102:IV2-IV13.
2000
-
Vascular biology: the past 50 years..
102:IV112-IV116.
2000
-
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial..
102:1761-1765.
2000
-
Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging..
102:1678-1683.
2000
-
Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice..
102:1684-1689.
2000
-
Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics..
102:1651-1656.
2000
-
Coronary artery angiography using multislice computed tomography images..
102:1589-1590.
2000
-
Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine..
102:1490-1496.
2000
-
Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators..
102:1375-1381.
2000
-
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators..
102:1101-1106.
2000
-
Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study..
102:852-857.
2000
-
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease..
102:728-735.
2000
-
Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells attenuates mitogenic signaling via G protein-coupled and platelet-derived growth factor receptors..
102:793-799.
2000
-
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial..
102:611-616.
2000
-
Concomitant endovascular repair of descending thoracic and abdominal aortic aneurysm..
102:E36.
2000
-
Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly..
102:642-648.
2000
-
Targeting patients undergoing angioplasty for thrombus inhibition: a cost-effectiveness and decision support model..
102:392-398.
2000
-
American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease..
102:126-140.
2000
-
Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo..
101:2833-2840.
2000
-
Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure..
101:2854-2862.
2000
-
Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group..
101:2788-2794.
2000
-
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators..
101:2557-2567.
2000
-
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial..
101:2231-2238.
2000
-
Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial..
101:2172-2177.
2000
-
ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy..
101:2138-2143.
2000
-
Anger proneness predicts coronary heart disease risk: prospective analysis from the atherosclerosis risk in communities (ARIC) study..
101:2034-2039.
2000
-
Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities..
101:2071-2077.
2000
-
Catecholamines, cardiac beta-adrenergic receptors, and heart failure..
101:1634-1637.
2000
-
Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke..
101:1483-1493.
2000
-
Heat shock protein 47 : a chaperone for the fibrous cap?.
101:1227-1228.
2000
-
Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes..
101:969-974.
2000
-
Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits..
101:1027-1033.
2000
-
Distinguishing mechanisms from markers of cardiac contractile dysfunction: more than 1 way to skin the cat of heart failure..
101:738-739.
2000
-
Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension : novel molecular adaptation to systolic load in absence of hypertrophy..
101:423-429.
2000
-
Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes..
101:366-371.
2000
-
Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance..
101:408-414.
2000
-
High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates..
101:178-184.
2000
-
Cardiovascular abnormalities in transgenic mice with reduced brown fat: an animal model of human obesity..
100:2177-2183.
1999
-
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation..
100:2067-2073.
1999
-
Clinical outcomes of bivalirudin for ischemic heart disease..
100:2049-2053.
1999
-
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function..
100:1992-2002.
1999
-
Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition..
100:1734-1743.
1999
-
Pursuing progress in acute coronary syndromes..
100:1586-1589.
1999
-
Skin manifestations, multiple aneurysms, and carotid-cavernous fistula in Ehlers-Danlos syndrome type IV..
100:e57-e58.
1999
-
Worried to death?.
100:1251-1252.
1999
-
Aerobic exercise training can reverse age-related peripheral circulatory changes in healthy older men..
100:1085-1094.
1999
-
Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators..
100:799-806.
1999
-
In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function..
100:648-653.
1999
-
Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction..
100:185-192.
1999
-
Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial..
100:14-20.
1999
-
Three-dimensional visualization of recurrent coarctation of the aorta by electron-beam tomography and MRI..
99:3086-3087.
1999
-
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience..
99:2892-2900.
1999
-
Enhanced contractility and decreased beta-adrenergic receptor kinase-1 in mice lacking endogenous norepinephrine and epinephrine..
99:2702-2707.
1999
-
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators..
99:2371-2377.
1999
-
Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy..
99:2192-2217.
1999
-
Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade..
99:1951-1958.
1999
-
Gender differences in survival in advanced heart failure. Insights from the FIRST study..
99:1816-1821.
1999
-
Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variables..
99:1843-1850.
1999
-
Differentiation of viable and nonviable myocardium by the use of three-dimensional tagged MRI in 2-day-old reperfused canine infarcts..
99:284-291.
1999
-
Response to letter regarding article, "surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience"..
131:e378-e379.
2015
-
Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
2021
-
Transplant-Free Survival and Interventions at 6 Years in the SVR Trial.
2018
-
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
2015
-
Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.
2015
-
Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database.
2014
-
Racial disparity persists after on-pump and off-pump coronary artery bypass grafting.
2009
-
Retrograde ascending aortic dissection during or after thoracic aortic stent graft placement: insight from the European registry on endovascular aortic repair complications.
2009
-
Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD.
2004
-
Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va.
2002
-
Report from the 94th Cardiovascular and Renal Drugs Advisory Committee Meeting, October 11, 2001.
2001